FEBUXOSTAT

FEBUXOSTAT was reported 17000 times

FEBUXOSTAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RED BLOOD CELL SEDIMENTATION RATE 129 0.4624
1 CONGENITAL DIAPHRAGMATIC ANOMALY 10 0.2778
2 CYTOMEGALOVIRUS NEPHRITIS 11 0.2075
3 GRANULOMA SKIN 145 0.1766
4 ENTHESOPATHY 247 0.1578
5 SPLENIC NECROSIS 13 0.1512
6 POLYCYSTIC LIVER DISEASE 13 0.1226
7 GOUTY TOPHUS 26 0.1171
8 BLOOD PARATHYROID HORMONE DECREASED 165 0.1113
9 TENOSYNOVITIS 249 0.0902
10 OSTEOMA 13 0.0722
11 PANNICULITIS 165 0.0681
12 ALANINE AMINOTRANSFERASE ABNORMAL 142 0.0673
13 SPLENIC CYST 14 0.0670
14 GLUCOSE URINE 10 0.0667
15 HAEMOGLOBIN URINE PRESENT 13 0.0640
16 RHEUMATOID NODULE 164 0.0595
17 RESPIRATORY TRACT HAEMORRHAGE 33 0.0553
18 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 13 0.0526
19 METASTASES TO SOFT TISSUE 13 0.0502
20 RHEUMATOID LUNG 46 0.0482
21 BLOOD URIC ACID DECREASED 20 0.0412
22 GOUT 700 0.0390
23 SPLENIC LESION 14 0.0378
24 C-REACTIVE PROTEIN ABNORMAL 239 0.0372
25 LORDOSIS 13 0.0370
26 SKIN NECROSIS 172 0.0331
27 DRUG TOLERANCE DECREASED 89 0.0317
28 TONGUE DISORDER 229 0.0316
29 DYSPNOEA PAROXYSMAL NOCTURNAL 20 0.0274
30 GOUTY ARTHRITIS 21 0.0263
31 NEPHROGENIC ANAEMIA 110 0.0237
32 HYPERURICAEMIA 93 0.0226
33 BLOOD URIC ACID ABNORMAL 9 0.0221
34 BLOOD URIC ACID INCREASED 127 0.0220
35 HYPERPARATHYROIDISM SECONDARY 55 0.0219
36 PROTHROMBIN TIME ABNORMAL 15 0.0217
37 TONSIL CANCER 17 0.0211
38 PNEUMONIA HAEMOPHILUS 10 0.0206
39 URINARY SEDIMENT PRESENT 13 0.0202
40 CEREBRAL ARTERY THROMBOSIS 10 0.0195
41 THALAMUS HAEMORRHAGE 16 0.0184
42 ORTHOSTATIC INTOLERANCE 13 0.0181
43 GRANULOMA 61 0.0176
44 HYPERCALCAEMIA 202 0.0163
45 SYSTEMIC INFECTION 27 0.0163
46 CARDIAC FAILURE CHRONIC 67 0.0157
47 RED BLOOD CELLS URINE POSITIVE 15 0.0155
48 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 10 0.0152
49 TUMOUR LYSIS SYNDROME 133 0.0151
50 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 10 0.0151
51 RED BLOOD CELL ABNORMALITY 14 0.0146
52 TENDONITIS 220 0.0142
53 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 15 0.0141
54 SUPERINFECTION BACTERIAL 11 0.0139
55 FOLATE DEFICIENCY 16 0.0138
56 SYNOVITIS 241 0.0134
57 HYPOPARATHYROIDISM 10 0.0130
58 BLISTER INFECTED 10 0.0128
59 RED BLOOD CELL SEDIMENTATION RATE INCREASED 140 0.0126
60 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 13 0.0125
61 DIFFERENTIATION SYNDROME 9 0.0123
62 DRUG ERUPTION 216 0.0122
63 DRUG TOLERANCE 59 0.0117
64 CORONAVIRUS TEST POSITIVE 12 0.0117
65 HAEMATOCRIT ABNORMAL 14 0.0114
66 PRERENAL FAILURE 16 0.0113
67 OSTEOCHONDROSIS 13 0.0112
68 FEAR OF INJECTION 79 0.0111
69 BASAL CELL CARCINOMA 172 0.0110
70 ULCER 174 0.0109
71 CARDIAC AMYLOIDOSIS 12 0.0109
72 FULMINANT TYPE 1 DIABETES MELLITUS 11 0.0107
73 ORTHOPNOEA 34 0.0107
74 PERIODONTITIS 23 0.0106
75 CARDIAC FAILURE ACUTE 69 0.0103
76 HYPERPHOSPHATAEMIA 22 0.0102
77 BLOOD BILIRUBIN ABNORMAL 13 0.0101
78 UPPER RESPIRATORY TRACT INFLAMMATION 12 0.0100
79 PHYSICAL DECONDITIONING 25 0.0097
80 URETEROLITHIASIS 10 0.0095
81 RHONCHI 13 0.0094
82 END STAGE RENAL DISEASE 171 0.0094
83 REBOUND ACID HYPERSECRETION 28 0.0092
84 LUNG OPACITY 24 0.0091
85 BRAIN NATRIURETIC PEPTIDE INCREASED 28 0.0091
86 SMALL INTESTINAL PERFORATION 17 0.0091
87 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 12 0.0085
88 RUBBER SENSITIVITY 13 0.0085
89 MEAN CELL HAEMOGLOBIN INCREASED 14 0.0084
90 CEREBELLAR INFARCTION 14 0.0083
91 DIABETIC NEPHROPATHY 18 0.0082
92 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 9 0.0080
93 RENAL ATROPHY 10 0.0080
94 WHITE BLOOD CELLS URINE POSITIVE 15 0.0080
95 SKIN ULCER 204 0.0079
96 MESOTHELIOMA 10 0.0077
97 IMMUNE-MEDIATED HEPATIC DISORDER 15 0.0077
98 SEBORRHOEIC KERATOSIS 11 0.0076
99 C-REACTIVE PROTEIN INCREASED 271 0.0074
100 CYTOMEGALOVIRUS TEST POSITIVE 13 0.0073
101 CONTRAINDICATED PRODUCT ADMINISTERED 220 0.0073
102 BILE DUCT STONE 23 0.0072
103 ANAEMIA MACROCYTIC 15 0.0070
104 AORTIC ARTERIOSCLEROSIS 18 0.0070
105 ASPARTATE AMINOTRANSFERASE INCREASED 369 0.0069
106 HYPOPROTEINAEMIA 13 0.0068
107 OSTEOLYSIS 14 0.0068
108 NORMOCYTIC ANAEMIA 10 0.0068
109 AORTIC VALVE STENOSIS 12 0.0067
110 HYPERKALAEMIA 235 0.0067
111 DIVERTICULUM INTESTINAL HAEMORRHAGIC 15 0.0067
112 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 10 0.0065
113 HAEMORRHAGE SUBCUTANEOUS 23 0.0065
114 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 16 0.0065
115 CHRONIC FATIGUE SYNDROME 9 0.0065
116 NEOPLASM SKIN 10 0.0064
117 RENAL IMPAIRMENT 541 0.0064
118 GLOMERULAR FILTRATION RATE DECREASED 79 0.0064
119 CHRONIC KIDNEY DISEASE 488 0.0064
120 BLOOD BLISTER 20 0.0064
121 BLOOD CREATININE INCREASED 416 0.0064
122 HYPOPITUITARISM 11 0.0063
123 CYTOKINE RELEASE SYNDROME 126 0.0063
124 EMBOLIC STROKE 22 0.0062
125 HYPOALBUMINAEMIA 48 0.0062
126 LINEAR IGA DISEASE 10 0.0060
127 AZOTAEMIA 24 0.0060
128 GENERALISED ERYTHEMA 34 0.0060
129 VENTRICULAR HYPOKINESIA 19 0.0059
130 TUBULOINTERSTITIAL NEPHRITIS 110 0.0059
131 ALANINE AMINOTRANSFERASE INCREASED 355 0.0058
132 UMBILICAL HERNIA 27 0.0058
133 ACUTE KIDNEY INJURY 881 0.0058
134 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
135 PSORIATIC ARTHROPATHY 233 0.0057
136 HEPATIC MASS 11 0.0057
137 PNEUMONIA BACTERIAL 52 0.0057
138 BENIGN PROSTATIC HYPERPLASIA 29 0.0056
139 HEPATIC CYST 19 0.0056
140 SKIN EROSION 18 0.0056
141 PEMPHIGOID 42 0.0056
142 INTERNATIONAL NORMALISED RATIO ABNORMAL 19 0.0055
143 HAEMOTHORAX 16 0.0055
144 DYSLIPIDAEMIA 28 0.0055
145 IMMUNE-MEDIATED LUNG DISEASE 10 0.0055
146 ESSENTIAL HYPERTENSION 10 0.0055
147 CALCIPHYLAXIS 10 0.0054
148 BLOOD PRESSURE SYSTOLIC INCREASED 106 0.0054
149 LACUNAR INFARCTION 13 0.0054
150 IMMUNE-MEDIATED HEPATITIS 11 0.0054
151 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 257 0.0053
152 CARDIAC FAILURE 428 0.0053
153 MIXED LIVER INJURY 16 0.0053
154 LOWER GASTROINTESTINAL HAEMORRHAGE 39 0.0053
155 BLOOD UREA INCREASED 87 0.0052
156 CONCOMITANT DISEASE AGGRAVATED 32 0.0052
157 CHOLANGITIS 32 0.0052
158 PNEUMONIA CYTOMEGALOVIRAL 10 0.0051
159 RIGHT VENTRICULAR FAILURE 36 0.0051
160 BLOOD PHOSPHORUS INCREASED 14 0.0051
161 ACUTE MYELOID LEUKAEMIA RECURRENT 11 0.0051
162 GASTROINTESTINAL OEDEMA 9 0.0051
163 MEAN CELL VOLUME INCREASED 13 0.0051
164 FIBRIN D DIMER INCREASED 18 0.0051
165 SMALL INTESTINAL HAEMORRHAGE 10 0.0050
166 DISSEMINATED INTRAVASCULAR COAGULATION 69 0.0049
167 VENOUS THROMBOSIS LIMB 10 0.0048
168 CARDIAC DYSFUNCTION 18 0.0048
169 RENAL TUBULAR NECROSIS 47 0.0048
170 CYTOMEGALOVIRUS COLITIS 11 0.0048
171 TROPONIN INCREASED 36 0.0047
172 LEFT VENTRICULAR FAILURE 16 0.0046
173 MYELOFIBROSIS 14 0.0046
174 IMMUNE-MEDIATED ENTEROCOLITIS 17 0.0046
175 TOXIC EPIDERMAL NECROLYSIS 70 0.0046
176 HEPATIC FUNCTION ABNORMAL 171 0.0046
177 RENAL FUNCTION TEST ABNORMAL 21 0.0045
178 CHOLESTATIC LIVER INJURY 10 0.0045
179 PNEUMOCYSTIS JIROVECII PNEUMONIA 45 0.0045
180 JOINT INJURY 95 0.0044
181 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 39 0.0044
182 COVID-19 PNEUMONIA 52 0.0044
183 NEUTROPHIL COUNT DECREASED 178 0.0044
184 OSTEOMYELITIS 79 0.0044
185 RASH PRURITIC 235 0.0043
186 ENTEROCOLITIS 25 0.0043
187 PNEUMONIA FUNGAL 17 0.0043
188 ATRIAL TACHYCARDIA 9 0.0043
189 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
190 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
191 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 10 0.0043
192 CREATININE RENAL CLEARANCE DECREASED 17 0.0042
193 INTERNATIONAL NORMALISED RATIO DECREASED 17 0.0042
194 HAEMOGLOBIN ABNORMAL 27 0.0042
195 INFUSION RELATED REACTION 276 0.0042
196 INFLAMMATION 213 0.0041
197 MUSCULOSKELETAL DISORDER 78 0.0041
198 CEREBRAL INFARCTION 99 0.0040
199 BLOOD CREATININE ABNORMAL 14 0.0040
200 FAECALOMA 22 0.0040
201 ATRIAL FLUTTER 32 0.0040
202 IRON DEFICIENCY ANAEMIA 37 0.0040
203 TACHYARRHYTHMIA 10 0.0040
204 THYROIDITIS 12 0.0040
205 CHRONIC GASTRITIS 9 0.0040
206 DISTRIBUTIVE SHOCK 9 0.0040
207 IMMUNE THROMBOCYTOPENIA 18 0.0039
208 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 16 0.0039
209 ACUTE MYELOID LEUKAEMIA 61 0.0039
210 HYPOKALAEMIA 180 0.0039
211 HAEMORRHOIDAL HAEMORRHAGE 19 0.0039
212 ACUTE MYOCARDIAL INFARCTION 114 0.0039
213 TUMOUR HAEMORRHAGE 11 0.0039
214 ODYNOPHAGIA 23 0.0038
215 LYMPHOCYTE COUNT DECREASED 68 0.0038
216 DUODENAL ULCER HAEMORRHAGE 11 0.0038
217 PROCEDURAL HAEMORRHAGE 15 0.0038
218 INTERSTITIAL LUNG DISEASE 185 0.0038
219 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
220 HYPOCALCAEMIA 72 0.0038
221 AMYLASE INCREASED 14 0.0038
222 GASTRIC ULCER HAEMORRHAGE 21 0.0038
223 APLASIA PURE RED CELL 13 0.0038
224 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
225 BLOOD POTASSIUM ABNORMAL 10 0.0037
226 ADRENAL INSUFFICIENCY 45 0.0037
227 CHOLECYSTITIS ACUTE 21 0.0037
228 BLOOD POTASSIUM INCREASED 60 0.0037
229 SHOCK HAEMORRHAGIC 30 0.0037
230 GASTRIC PERFORATION 10 0.0037
231 HYPERCAPNIA 11 0.0036
232 NEPHROPATHY 34 0.0036
233 BACTERAEMIA 43 0.0036
234 PROTEIN URINE PRESENT 18 0.0036
235 MELAENA 79 0.0036
236 SPUTUM DISCOLOURED 34 0.0036
237 ILEUS PARALYTIC 16 0.0036
238 CARDIAC TAMPONADE 17 0.0036
239 POTENTIATING DRUG INTERACTION 12 0.0036
240 SUPRAVENTRICULAR EXTRASYSTOLES 12 0.0035
241 NON-SMALL CELL LUNG CANCER 17 0.0035
242 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 21 0.0035
243 ERYTHEMA MULTIFORME 33 0.0035
244 RENAL FAILURE 469 0.0035
245 FEBRILE NEUTROPENIA 234 0.0035
246 HAEMOGLOBIN INCREASED 16 0.0035
247 SPLENOMEGALY 41 0.0035
248 ANURIA 30 0.0035
249 PLATELET COUNT ABNORMAL 21 0.0035
250 BLOOD LACTATE DEHYDROGENASE INCREASED 55 0.0035
251 HEPATIC LESION 15 0.0035
252 PULMONARY ARTERIAL HYPERTENSION 50 0.0034
253 CAROTID ARTERY STENOSIS 12 0.0034
254 GASTRITIS EROSIVE 16 0.0034
255 HAEMORRHAGIC ANAEMIA 15 0.0034
256 HEPATITIS ACUTE 22 0.0034
257 NEPHROTIC SYNDROME 23 0.0034
258 HYPOVOLAEMIC SHOCK 16 0.0033
259 STEVENS-JOHNSON SYNDROME 74 0.0033
260 CORONAVIRUS INFECTION 22 0.0033
261 LUNG ADENOCARCINOMA 10 0.0033
262 DERMATITIS BULLOUS 24 0.0033
263 SPINAL OSTEOARTHRITIS 29 0.0033
264 KERATITIS 10 0.0033
265 PULMONARY TOXICITY 23 0.0032
266 CYTOMEGALOVIRUS INFECTION 54 0.0032
267 THERAPY NON-RESPONDER 146 0.0032
268 STAPHYLOCOCCAL SEPSIS 16 0.0032
269 OLIGURIA 20 0.0032
270 PLEURAL EFFUSION 196 0.0032
271 PULMONARY FUNCTION TEST DECREASED 14 0.0032
272 CHRONIC LYMPHOCYTIC LEUKAEMIA 15 0.0032
273 RHABDOMYOLYSIS 131 0.0031
274 ANAEMIA 598 0.0031
275 PNEUMONIA ASPIRATION 78 0.0031
276 MYOCLONUS 37 0.0031
277 STRESS CARDIOMYOPATHY 18 0.0031
278 FLANK PAIN 29 0.0031
279 ANGINA UNSTABLE 20 0.0031
280 LARGE INTESTINE POLYP 21 0.0030
281 HEPATOCELLULAR CARCINOMA 23 0.0030
282 ALTERED STATE OF CONSCIOUSNESS 65 0.0030
283 CORONARY ARTERY STENOSIS 15 0.0030
284 DUODENAL ULCER 21 0.0030
285 PULMONARY FIBROSIS 57 0.0030
286 PLATELET COUNT DECREASED 316 0.0030
287 HYPOMAGNESAEMIA 41 0.0029
288 CYTOMEGALOVIRUS INFECTION REACTIVATION 13 0.0029
289 OEDEMA PERIPHERAL 358 0.0029
290 MYELODYSPLASTIC SYNDROME 42 0.0029
291 GENERAL PHYSICAL HEALTH DETERIORATION 335 0.0029
292 DYSPNOEA EXERTIONAL 109 0.0029
293 APPETITE DISORDER 19 0.0029
294 DRUG INTOLERANCE 276 0.0029
295 EOSINOPHILIC PNEUMONIA 9 0.0029
296 UPPER GASTROINTESTINAL HAEMORRHAGE 48 0.0029
297 FAECAL CALPROTECTIN INCREASED 9 0.0028
298 DRUG-INDUCED LIVER INJURY 89 0.0028
299 ORGANISING PNEUMONIA 14 0.0028
300 MULTIPLE ORGAN DYSFUNCTION SYNDROME 80 0.0028
301 SPINAL COMPRESSION FRACTURE 23 0.0028
302 TOXIC SKIN ERUPTION 28 0.0028
303 ACUTE CORONARY SYNDROME 23 0.0028
304 CARDIAC FAILURE CONGESTIVE 222 0.0028
305 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15 0.0028
306 LACTIC ACIDOSIS 89 0.0027
307 MUSCLE HAEMORRHAGE 11 0.0027
308 FEMORAL NECK FRACTURE 14 0.0027
309 CYSTITIS HAEMORRHAGIC 11 0.0027
310 DIFFUSE LARGE B-CELL LYMPHOMA 21 0.0027
311 BLOOD CREATINE PHOSPHOKINASE INCREASED 78 0.0027
312 HUMERUS FRACTURE 13 0.0027
313 ATELECTASIS 26 0.0027
314 PROTEINURIA 51 0.0027
315 PROTHROMBIN TIME PROLONGED 16 0.0027
316 HAEMATOCRIT DECREASED 53 0.0027
317 IRON DEFICIENCY 12 0.0027
318 MYELOSUPPRESSION 96 0.0027
319 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 20 0.0027
320 PULMONARY CONGESTION 35 0.0027
321 URINE OUTPUT DECREASED 23 0.0026
322 DISEASE COMPLICATION 12 0.0026
323 ASCITES 77 0.0026
324 HYPERNATRAEMIA 13 0.0026
325 VENTRICULAR TACHYCARDIA 43 0.0026
326 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 67 0.0026
327 RENAL INJURY 77 0.0026
328 ANGINA PECTORIS 74 0.0026
329 ABSCESS LIMB 11 0.0026
330 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
331 HAEMOLYTIC ANAEMIA 23 0.0026
332 THROMBOTIC MICROANGIOPATHY 25 0.0026
333 HYPERTRIGLYCERIDAEMIA 15 0.0026
334 HICCUPS 21 0.0026
335 SUBARACHNOID HAEMORRHAGE 26 0.0026
336 PANCREATITIS ACUTE 57 0.0025
337 HYPOXIA 89 0.0025
338 RENAL CYST 20 0.0025
339 HYPERLIPIDAEMIA 30 0.0025
340 KIDNEY TRANSPLANT REJECTION 12 0.0025
341 ENTERITIS 16 0.0025
342 BONE LESION 9 0.0025
343 TYPE 1 DIABETES MELLITUS 15 0.0025
344 RHINITIS ALLERGIC 11 0.0025
345 ATRIAL FIBRILLATION 240 0.0025
346 ATRIOVENTRICULAR BLOCK 19 0.0025
347 FOOD INTOLERANCE 9 0.0025
348 CHOLECYSTITIS 29 0.0024
349 HAEMATOCHEZIA 134 0.0024
350 TORSADE DE POINTES 19 0.0024
351 PANCYTOPENIA 134 0.0024
352 TOXIC ENCEPHALOPATHY 12 0.0024
353 ROSACEA 11 0.0024
354 BUNDLE BRANCH BLOCK LEFT 10 0.0024
355 ACIDOSIS 18 0.0024
356 FEBRILE BONE MARROW APLASIA 10 0.0024
357 EOSINOPHILIA 41 0.0023
358 DEVICE RELATED INFECTION 36 0.0023
359 LOW DENSITY LIPOPROTEIN INCREASED 18 0.0023
360 BLOOD TRIGLYCERIDES INCREASED 41 0.0023
361 HAEMATOMA 60 0.0023
362 TREATMENT FAILURE 191 0.0023
363 PULMONARY HYPERTENSION 48 0.0023
364 TRANSFUSION 24 0.0023
365 HYPOGAMMAGLOBULINAEMIA 15 0.0023
366 INCREASED TENDENCY TO BRUISE 21 0.0023
367 THERAPEUTIC PRODUCT EFFECT DECREASED 102 0.0023
368 SEPTIC SHOCK 99 0.0023
369 HYDRONEPHROSIS 17 0.0023
370 DIZZINESS POSTURAL 22 0.0023
371 TRICUSPID VALVE INCOMPETENCE 18 0.0023
372 SCOLIOSIS 14 0.0023
373 BLOOD CREATINE INCREASED 10 0.0023
374 ARTERIOSCLEROSIS 21 0.0022
375 HYPERVOLAEMIA 11 0.0022
376 HAEMATURIA 76 0.0022
377 LIPASE INCREASED 17 0.0022
378 OEDEMA 120 0.0022
379 CORONARY ARTERY DISEASE 67 0.0022
380 PERICARDIAL EFFUSION 51 0.0022
381 PRESCRIBED UNDERDOSE 44 0.0022
382 RED BLOOD CELL COUNT DECREASED 63 0.0022
383 SARS-COV-2 TEST POSITIVE 29 0.0022
384 PYELONEPHRITIS 19 0.0022
385 ECCHYMOSIS 15 0.0022
386 CELLULITIS 110 0.0022
387 PERIPHERAL SWELLING 335 0.0022
388 AORTIC DISSECTION 9 0.0022
389 PULMONARY HAEMORRHAGE 17 0.0022
390 ELECTROCARDIOGRAM ABNORMAL 17 0.0022
391 HYPOTHYROIDISM 69 0.0022
392 THERAPEUTIC RESPONSE DECREASED 131 0.0022
393 CONGESTIVE CARDIOMYOPATHY 9 0.0022
394 METABOLIC ACIDOSIS 69 0.0022
395 HEPATITIS B 13 0.0022
396 HEPATIC ENZYME INCREASED 147 0.0022
397 GASTRIC DISORDER 74 0.0022
398 ARTHRITIS INFECTIVE 10 0.0022
399 ELECTROLYTE IMBALANCE 25 0.0021
400 PNEUMOTHORAX 34 0.0021
401 HAEMOGLOBIN DECREASED 220 0.0021
402 LIVER FUNCTION TEST ABNORMAL 62 0.0021
403 PALLOR 58 0.0021
404 RENAL DISORDER 99 0.0021
405 WHITE BLOOD CELL COUNT DECREASED 230 0.0021
406 MITRAL VALVE INCOMPETENCE 24 0.0021
407 LIVER DISORDER 94 0.0021
408 AORTIC VALVE INCOMPETENCE 9 0.0021
409 DRUG LEVEL INCREASED 35 0.0021
410 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
411 HIATUS HERNIA 27 0.0021
412 WHITE BLOOD CELL COUNT INCREASED 80 0.0021
413 MYOPATHY 18 0.0021
414 ATRIOVENTRICULAR BLOCK FIRST DEGREE 9 0.0021
415 COLITIS ISCHAEMIC 14 0.0021
416 INTERNATIONAL NORMALISED RATIO INCREASED 59 0.0021
417 RASH VESICULAR 10 0.0021
418 CEREBRAL HAEMORRHAGE 74 0.0021
419 EYELID OEDEMA 24 0.0021
420 FLUID RETENTION 105 0.0021
421 NEUROTOXICITY 36 0.0021
422 AGRANULOCYTOSIS 38 0.0020
423 EOSINOPHIL COUNT INCREASED 17 0.0020
424 BODY TEMPERATURE DECREASED 20 0.0020
425 HYPOPHOSPHATAEMIA 15 0.0020
426 DECREASED APPETITE 471 0.0020
427 ACUTE RESPIRATORY FAILURE 39 0.0020
428 HYPONATRAEMIA 114 0.0020
429 ILEUS 25 0.0020
430 HAEMOPTYSIS 56 0.0020
431 EPISTAXIS 150 0.0020
432 UVEITIS 27 0.0020
433 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44 0.0020
434 ARRHYTHMIA 94 0.0020
435 MYASTHENIA GRAVIS 16 0.0020
436 COAGULOPATHY 33 0.0020
437 DIALYSIS 28 0.0020
438 BLOOD PRESSURE DECREASED 131 0.0020
439 RENAL FAILURE CHRONIC 15 0.0019
440 COLON CANCER 29 0.0019
441 TENDON RUPTURE 24 0.0019
442 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
443 ARTHROPATHY 107 0.0019
444 FAECES SOFT 14 0.0019
445 ARTHRITIS 151 0.0019
446 GASTROENTERITIS 28 0.0019
447 BRADYCARDIA 101 0.0019
448 RHEUMATOID ARTHRITIS 216 0.0019
449 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 135 0.0019
450 SERUM FERRITIN INCREASED 10 0.0019
451 ORTHOSTATIC HYPOTENSION 33 0.0019
452 MYOSITIS 17 0.0019
453 GASTROINTESTINAL HAEMORRHAGE 158 0.0019
454 SUBDURAL HAEMATOMA 27 0.0019
455 JOINT EFFUSION 13 0.0019
456 CARDIOGENIC SHOCK 27 0.0019
457 PSEUDOMONAS INFECTION 16 0.0019
458 RASH 812 0.0019
459 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
460 ANAL ABSCESS 10 0.0019
461 PLEURISY 11 0.0019
462 RASH MACULO-PAPULAR 41 0.0018
463 PLATELET COUNT INCREASED 24 0.0018
464 TACHYPNOEA 25 0.0018
465 POOR VENOUS ACCESS 19 0.0018
466 VENTRICULAR EXTRASYSTOLES 19 0.0018
467 DEHYDRATION 243 0.0018
468 RESPIRATORY FAILURE 132 0.0018
469 SQUAMOUS CELL CARCINOMA 17 0.0018
470 BRONCHOPULMONARY ASPERGILLOSIS 14 0.0018
471 POST PROCEDURAL HAEMORRHAGE 21 0.0018
472 GASTRIC ULCER 34 0.0018
473 CARDIOMEGALY 22 0.0018
474 LYMPHADENOPATHY 63 0.0018
475 METASTASES TO LYMPH NODES 12 0.0018
476 GENERALISED OEDEMA 22 0.0018
477 SEPSIS 198 0.0018
478 POLLAKIURIA 74 0.0018
479 LYMPHOPENIA 25 0.0018
480 CARDIOMYOPATHY 26 0.0018
481 PNEUMONIA 569 0.0018
482 BLOOD MAGNESIUM DECREASED 15 0.0017
483 RASH GENERALISED 45 0.0017
484 ENCEPHALITIS 12 0.0017
485 HYPERGLYCAEMIA 63 0.0017
486 LIVER FUNCTION TEST INCREASED 37 0.0017
487 APLASTIC ANAEMIA 9 0.0017
488 HEPATIC STEATOSIS 32 0.0017
489 PRODUCTIVE COUGH 82 0.0017
490 THROMBOCYTOPENIA 191 0.0017
491 HYPERTENSIVE CRISIS 19 0.0017
492 ERYTHEMA 348 0.0017
493 GINGIVAL BLEEDING 23 0.0017
494 COMPRESSION FRACTURE 9 0.0017
495 PRODUCT PRESCRIBING ERROR 40 0.0017
496 DRUG INTERACTION 265 0.0017
497 DERMATITIS ALLERGIC 21 0.0017
498 HEPATIC FAILURE 50 0.0017
499 FLUID OVERLOAD 24 0.0016
500 CIRCULATORY COLLAPSE 28 0.0016
501 CYTOPENIA 20 0.0016
502 PYREXIA 565 0.0016
503 VASCULITIS 19 0.0016
504 THIRST 29 0.0016
505 ABDOMINAL PAIN LOWER 41 0.0016
506 MALNUTRITION 18 0.0016
507 HEPATIC ENCEPHALOPATHY 15 0.0016
508 NEPHROPATHY TOXIC 18 0.0016
509 MUSCULOSKELETAL STIFFNESS 140 0.0016
510 URINARY RETENTION 53 0.0016
511 MOBILITY DECREASED 114 0.0016
512 HYPERTENSION 336 0.0016
513 LARGE INTESTINE PERFORATION 11 0.0016
514 ACUTE RESPIRATORY DISTRESS SYNDROME 28 0.0016
515 JOINT SWELLING 191 0.0016
516 PHOTOPSIA 10 0.0016
517 HYPOGLYCAEMIA 76 0.0016
518 NOCTURIA 19 0.0016
519 NEUTROPHIL COUNT INCREASED 16 0.0016
520 HYPERCHOLESTEROLAEMIA 15 0.0016
521 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 36 0.0015
522 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
523 FULL BLOOD COUNT DECREASED 31 0.0015
524 MUCOSAL INFLAMMATION 40 0.0015
525 DEEP VEIN THROMBOSIS 99 0.0015
526 FAECES DISCOLOURED 33 0.0015
527 BLOOD THYROID STIMULATING HORMONE INCREASED 14 0.0015
528 HEAD INJURY 48 0.0015
529 RENAL FAILURE ACUTE 64 0.0015
530 MOUTH HAEMORRHAGE 11 0.0015
531 CONTUSION 144 0.0015
532 CONSTIPATION 324 0.0015
533 SHOCK 34 0.0015
534 PULMONARY OEDEMA 66 0.0015
535 KETOACIDOSIS 11 0.0015
536 PURPURA 13 0.0015
537 CHROMATURIA 33 0.0015
538 HEART RATE IRREGULAR 33 0.0015
539 CHOLESTASIS 28 0.0015
540 JAUNDICE 39 0.0014
541 PERITONITIS 30 0.0014
542 BACTERIAL INFECTION 27 0.0014
543 DYSURIA 53 0.0014
544 NEPHROLITHIASIS 66 0.0014
545 HEPATIC CIRRHOSIS 27 0.0014
546 HYPOTENSION 287 0.0014
547 BLOOD POTASSIUM DECREASED 43 0.0014
548 PAPULE 10 0.0014
549 SUDDEN DEATH 15 0.0014
550 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
551 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
552 DIVERTICULUM 10 0.0014
553 BLOOD BILIRUBIN INCREASED 38 0.0014
554 MYOCARDIAL ISCHAEMIA 16 0.0014
555 RETINAL HAEMORRHAGE 10 0.0014
556 DIARRHOEA 904 0.0014
557 ABDOMINAL DISCOMFORT 234 0.0014
558 LIVER INJURY 34 0.0014
559 GINGIVAL PAIN 11 0.0014
560 RECALLED PRODUCT ADMINISTERED 13 0.0014
561 SLEEP APNOEA SYNDROME 26 0.0014
562 DECUBITUS ULCER 11 0.0013
563 SKIN DISORDER 45 0.0013
564 ISCHAEMIC STROKE 24 0.0013
565 PRESCRIBED OVERDOSE 26 0.0013
566 RESPIRATORY DISTRESS 37 0.0013
567 DERMATITIS 28 0.0013
568 ELECTROCARDIOGRAM QT PROLONGED 48 0.0013
569 BLOOD PRESSURE INCREASED 204 0.0013
570 BLOOD CALCIUM DECREASED 15 0.0013
571 HEPATOMEGALY 13 0.0013
572 HERPES ZOSTER 76 0.0013
573 NEURALGIA 32 0.0013
574 INTERNAL HAEMORRHAGE 15 0.0013
575 CORONARY ARTERY OCCLUSION 18 0.0013
576 GASTRIC HAEMORRHAGE 15 0.0013
577 DRUG PRESCRIBING ERROR 25 0.0013
578 CONDITION AGGRAVATED 395 0.0013
579 METASTASES TO LUNG 15 0.0013
580 PHARYNGITIS 16 0.0013
581 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
582 EJECTION FRACTION DECREASED 20 0.0013
583 HAEMORRHAGIC STROKE 10 0.0013
584 ENCEPHALOPATHY 31 0.0013
585 VENTRICULAR FIBRILLATION 14 0.0013
586 PRODUCT USE ISSUE 236 0.0013
587 PNEUMONITIS 34 0.0012
588 TRANSPLANT REJECTION 10 0.0012
589 EYE INFECTION 14 0.0012
590 COLITIS 47 0.0012
591 FEEDING DISORDER 25 0.0012
592 SCRATCH 13 0.0012
593 LYMPHOMA 19 0.0012
594 LIMB DISCOMFORT 38 0.0012
595 DIVERTICULITIS 34 0.0012
596 RENAL PAIN 13 0.0012
597 MYOCARDITIS 14 0.0012
598 STOMATITIS 74 0.0012
599 INFECTION 176 0.0012
600 LEUKOCYTOSIS 22 0.0012
601 URINARY INCONTINENCE 36 0.0012
602 NEUTROPENIA 165 0.0012
603 DEPRESSED LEVEL OF CONSCIOUSNESS 48 0.0012
604 HYPOPHAGIA 31 0.0012
605 URINARY TRACT INFECTION 206 0.0012
606 SYNCOPE 120 0.0012
607 COVID-19 210 0.0012
608 SKIN LACERATION 13 0.0012
609 METASTASES TO LIVER 21 0.0012
610 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
611 BLOOD GLUCOSE ABNORMAL 22 0.0012
612 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
613 FACE OEDEMA 20 0.0012
614 MUSCLE ATROPHY 15 0.0012
615 SENSORY DISTURBANCE 19 0.0012
616 BLOOD IRON DECREASED 14 0.0012
617 HAEMORRHOIDS 23 0.0012
618 HYPERTHYROIDISM 17 0.0012
619 CARDIO-RESPIRATORY ARREST 49 0.0012
620 ERECTILE DYSFUNCTION 30 0.0012
621 HELICOBACTER INFECTION 12 0.0012
622 DIABETES MELLITUS 89 0.0012
623 BLOOD SODIUM DECREASED 22 0.0012
624 SKIN INFECTION 13 0.0012
625 BLOOD URINE PRESENT 22 0.0012
626 CHOLELITHIASIS 38 0.0012
627 PRURITUS GENERALISED 25 0.0012
628 HYPERSENSITIVITY 214 0.0012
629 DYSPNOEA 651 0.0011
630 WEIGHT FLUCTUATION 12 0.0011
631 HAEMATEMESIS 29 0.0011
632 NAIL DISORDER 10 0.0011
633 BLOOD ALBUMIN DECREASED 9 0.0011
634 LUNG INFILTRATION 10 0.0011
635 FALL 375 0.0011
636 TRANSAMINASES INCREASED 25 0.0011
637 DELIRIUM 39 0.0011
638 OXYGEN SATURATION DECREASED 63 0.0011
639 ARTHRALGIA 465 0.0011
640 BLISTER 62 0.0011
641 NAUSEA 870 0.0011
642 EXOSTOSIS 10 0.0011
643 NEOPLASM PROGRESSION 38 0.0011
644 LOCAL SWELLING 19 0.0011
645 UROSEPSIS 10 0.0011
646 UNDERDOSE 79 0.0011
647 BLOOD TEST ABNORMAL 15 0.0011
648 OBESITY 17 0.0011
649 MYOCARDIAL INFARCTION 186 0.0011
650 ABSCESS 17 0.0011
651 SKELETAL INJURY 11 0.0011
652 TOOTH INFECTION 14 0.0011
653 NEUROPATHY PERIPHERAL 101 0.0011
654 SINUS TACHYCARDIA 15 0.0011
655 MUSCULAR WEAKNESS 120 0.0011
656 ADVERSE REACTION 14 0.0011
657 FOLLICULITIS 11 0.0010
658 TREATMENT NONCOMPLIANCE 57 0.0010
659 BRONCHITIS 77 0.0010
660 URTICARIA 174 0.0010
661 OSTEOARTHRITIS 44 0.0010
662 HYPOKINESIA 15 0.0010
663 GASTRITIS 27 0.0010
664 VITAMIN D DEFICIENCY 10 0.0010
665 ACUTE HEPATIC FAILURE 14 0.0010
666 COLD SWEAT 18 0.0010
667 IMMUNODEFICIENCY 15 0.0010
668 RHINORRHOEA 65 0.0010
669 RASH ERYTHEMATOUS 48 0.0010
670 FRACTURE 19 0.0010
671 PANCREATITIS 53 0.0010
672 PULMONARY EMBOLISM 95 0.0010
673 HEPATITIS C 12 0.0010
674 LOSS OF CONSCIOUSNESS 127 0.0010
675 LOWER LIMB FRACTURE 19 0.0010
676 INTESTINAL PERFORATION 11 0.0010
677 HIP ARTHROPLASTY 15 0.0010
678 PARALYSIS 14 0.0010
679 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 51 0.0010
680 ABDOMINAL PAIN 226 0.0010
681 ANAPHYLACTIC SHOCK 25 0.0010
682 CHEST PAIN 179 0.0010
683 HYPERBILIRUBINAEMIA 10 0.0010
684 HAIR COLOUR CHANGES 12 0.0010
685 APPENDICITIS 9 0.0010
686 TENDERNESS 10 0.0010
687 DISORIENTATION 38 0.0010
688 PETECHIAE 10 0.0010
689 PALPITATIONS 112 0.0010
690 HEADACHE 599 0.0010
691 PAIN IN JAW 27 0.0010
692 PERICARDITIS 16 0.0010
693 FLATULENCE 54 0.0010
694 MALAISE 415 0.0009
695 DISEASE RECURRENCE 45 0.0009
696 RESPIRATORY ARREST 26 0.0009
697 HEPATIC CYTOLYSIS 12 0.0009
698 SCIATICA 15 0.0009
699 RASH PAPULAR 21 0.0009
700 TASTE DISORDER 19 0.0009
701 HAEMORRHAGE INTRACRANIAL 14 0.0009
702 SKIN DISCOLOURATION 43 0.0009
703 INFUSION SITE PAIN 12 0.0009
704 MYALGIA 158 0.0009
705 GASTROOESOPHAGEAL REFLUX DISEASE 74 0.0009
706 SEASONAL ALLERGY 13 0.0009
707 MUSCULOSKELETAL PAIN 48 0.0009
708 WOUND INFECTION 10 0.0009
709 PAIN IN EXTREMITY 269 0.0009
710 LOCALISED INFECTION 22 0.0009
711 ASTHENIA 342 0.0009
712 UPPER RESPIRATORY TRACT INFECTION 42 0.0009
713 PHOTOSENSITIVITY REACTION 15 0.0009
714 SWELLING FACE 59 0.0009
715 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
716 GAIT INABILITY 30 0.0009
717 COUGH 251 0.0009
718 THROMBOSIS 72 0.0009
719 WOUND 25 0.0009
720 ORAL PAIN 20 0.0009
721 INCREASED APPETITE 17 0.0009
722 HALLUCINATION 67 0.0009
723 GLAUCOMA 17 0.0009
724 OFF LABEL USE 772 0.0009
725 CYSTITIS 28 0.0009
726 SKIN HAEMORRHAGE 13 0.0009
727 WHEEZING 52 0.0009
728 SKIN LESION 24 0.0009
729 INSOMNIA 233 0.0009
730 MOVEMENT DISORDER 28 0.0009
731 VIRAL INFECTION 29 0.0009
732 PROSTATIC SPECIFIC ANTIGEN INCREASED 12 0.0009
733 BACK PAIN 201 0.0009
734 ABDOMINAL DISTENSION 90 0.0009
735 CHEST DISCOMFORT 88 0.0009
736 BLOOD COUNT ABNORMAL 13 0.0009
737 BLINDNESS UNILATERAL 12 0.0008
738 FOOT FRACTURE 16 0.0008
739 BONE MARROW FAILURE 17 0.0008
740 POLYNEUROPATHY 10 0.0008
741 GASTROENTERITIS VIRAL 15 0.0008
742 WEIGHT DECREASED 231 0.0008
743 CYANOSIS 13 0.0008
744 BURSITIS 10 0.0008
745 CONFUSIONAL STATE 133 0.0008
746 ASPIRATION 9 0.0008
747 JOINT RANGE OF MOTION DECREASED 11 0.0008
748 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 15 0.0008
749 RESPIRATORY TRACT CONGESTION 13 0.0008
750 GASTROINTESTINAL PAIN 9 0.0008
751 PRURITUS 314 0.0008
752 RECTAL HAEMORRHAGE 35 0.0008
753 DISEASE PROGRESSION 96 0.0008
754 HYPOAESTHESIA 121 0.0008
755 FEMUR FRACTURE 25 0.0008
756 FATIGUE 628 0.0008
757 UPPER LIMB FRACTURE 16 0.0008
758 ADVERSE EVENT 74 0.0008
759 CARDIAC ARREST 66 0.0008
760 SPINAL FRACTURE 16 0.0008
761 EATING DISORDER 17 0.0008
762 HEART RATE INCREASED 79 0.0008
763 INTESTINAL OBSTRUCTION 30 0.0008
764 MUSCLE SPASMS 146 0.0008
765 BLOOD PRESSURE FLUCTUATION 19 0.0008
766 FEELING COLD 22 0.0008
767 DERMATITIS CONTACT 9 0.0008
768 DIZZINESS 393 0.0008
769 DEMENTIA 22 0.0008
770 CARPAL TUNNEL SYNDROME 11 0.0008
771 TINNITUS 36 0.0008
772 HEPATITIS 20 0.0008
773 PRESYNCOPE 19 0.0008
774 LIP SWELLING 26 0.0008
775 ROTATOR CUFF SYNDROME 10 0.0008
776 RIB FRACTURE 16 0.0008
777 CHILLS 91 0.0008
778 HAEMORRHAGE 81 0.0008
779 LIMB INJURY 21 0.0008
780 HEART RATE DECREASED 27 0.0008
781 ANGIOEDEMA 34 0.0008
782 ORAL HERPES 15 0.0008
783 WEIGHT INCREASED 172 0.0008
784 RESPIRATORY TRACT INFECTION 20 0.0008
785 HYPERSOMNIA 22 0.0008
786 MOUTH ULCERATION 16 0.0008
787 IMMUNE SYSTEM DISORDER 10 0.0008
788 CEREBROVASCULAR ACCIDENT 127 0.0007
789 DYSARTHRIA 28 0.0007
790 PLASMA CELL MYELOMA 29 0.0007
791 SKIN CANCER 16 0.0007
792 PRODUCT ADMINISTRATION ERROR 15 0.0007
793 MUSCLE TIGHTNESS 12 0.0007
794 LEUKOPENIA 37 0.0007
795 PULMONARY MASS 11 0.0007
796 BACK DISORDER 12 0.0007
797 VOMITING 346 0.0007
798 DYSPHONIA 43 0.0007
799 LUNG DISORDER 36 0.0007
800 HEAD DISCOMFORT 13 0.0007
801 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
802 BALANCE DISORDER 63 0.0007
803 ALOPECIA 143 0.0007
804 GAIT DISTURBANCE 139 0.0007
805 CATARACT 43 0.0007
806 TACHYCARDIA 64 0.0007
807 FUNGAL INFECTION 24 0.0007
808 TOOTH DISORDER 16 0.0007
809 ABDOMINAL PAIN UPPER 148 0.0007
810 THYROID DISORDER 11 0.0007
811 KIDNEY INFECTION 14 0.0007
812 TYPE 2 DIABETES MELLITUS 24 0.0007
813 LETHARGY 41 0.0007
814 KNEE ARTHROPLASTY 15 0.0007
815 MUSCULOSKELETAL CHEST PAIN 11 0.0007
816 CANDIDA INFECTION 12 0.0007
817 HEMIPARESIS 12 0.0007
818 SWELLING 66 0.0007
819 BRAIN FOG 11 0.0007
820 PAIN 431 0.0007
821 INTENTIONAL DOSE OMISSION 20 0.0007
822 CONJUNCTIVITIS 13 0.0007
823 STAPHYLOCOCCAL INFECTION 23 0.0007
824 MUSCULOSKELETAL DISCOMFORT 12 0.0007
825 APHASIA 21 0.0007
826 VISION BLURRED 95 0.0007
827 DEAFNESS 18 0.0007
828 ABASIA 17 0.0007
829 OSTEONECROSIS OF JAW 17 0.0007
830 ANKYLOSING SPONDYLITIS 9 0.0007
831 INFLUENZA 76 0.0007
832 CARDIOVASCULAR DISORDER 17 0.0007
833 NASOPHARYNGITIS 123 0.0007
834 FREQUENT BOWEL MOVEMENTS 18 0.0007
835 MEDICATION ERROR 37 0.0007
836 LOWER RESPIRATORY TRACT INFECTION 30 0.0007
837 GASTROINTESTINAL DISORDER 59 0.0007
838 DIPLOPIA 17 0.0007
839 HIP FRACTURE 21 0.0007
840 DYSPEPSIA 64 0.0006
841 NASAL CONGESTION 38 0.0006
842 ANKLE FRACTURE 10 0.0006
843 DYSPHAGIA 61 0.0006
844 AGEUSIA 16 0.0006
845 CARDIAC DISORDER 60 0.0006
846 OVERDOSE 138 0.0006
847 HOT FLUSH 48 0.0006
848 MALIGNANT NEOPLASM PROGRESSION 65 0.0006
849 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
850 GASTRIC CANCER 16 0.0006
851 LACRIMATION INCREASED 19 0.0006
852 ACCIDENTAL OVERDOSE 23 0.0006
853 NECK PAIN 35 0.0006
854 DEATH 538 0.0006
855 BLOOD CHOLESTEROL INCREASED 29 0.0006
856 ROAD TRAFFIC ACCIDENT 26 0.0006
857 ERUCTATION 12 0.0006
858 UNRESPONSIVE TO STIMULI 16 0.0006
859 DYSSTASIA 18 0.0006
860 OROPHARYNGEAL PAIN 57 0.0006
861 HALLUCINATION, VISUAL 13 0.0006
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 110 0.0006
863 JOINT STIFFNESS 16 0.0006
864 METASTASES TO BONE 10 0.0006
865 COMA 29 0.0006
866 SWOLLEN TONGUE 19 0.0006
867 SOMNOLENCE 122 0.0006
868 BONE DISORDER 11 0.0006
869 BLOOD GLUCOSE INCREASED 113 0.0006
870 AMNESIA 39 0.0006
871 PRODUCT DOSE OMISSION 39 0.0006
872 TREMOR 99 0.0006
873 BODY TEMPERATURE INCREASED 12 0.0006
874 SINUSITIS 60 0.0006
875 RESTLESSNESS 21 0.0006
876 THERAPY INTERRUPTED 41 0.0006
877 ECZEMA 30 0.0006
878 FEELING HOT 35 0.0006
879 SKIN EXFOLIATION 48 0.0006
880 RESPIRATORY DISORDER 17 0.0006
881 DYSGEUSIA 42 0.0006
882 BONE PAIN 33 0.0006
883 BLOOD GLUCOSE DECREASED 27 0.0006
884 NIGHT SWEATS 18 0.0006
885 PAIN OF SKIN 15 0.0006
886 EPILEPSY 17 0.0006
887 VISUAL IMPAIRMENT 68 0.0005
888 IMPAIRED HEALING 18 0.0005
889 THERAPY CESSATION 28 0.0005
890 PRODUCT USE IN UNAPPROVED INDICATION 134 0.0005
891 SLEEP DISORDER 38 0.0005
892 DRUG INEFFECTIVE 709 0.0005
893 LUNG NEOPLASM MALIGNANT 22 0.0005
894 FEELING ABNORMAL 126 0.0005
895 INTENTIONAL PRODUCT USE ISSUE 46 0.0005
896 VERTIGO 32 0.0005
897 PANCREATIC CARCINOMA 15 0.0005
898 EAR PAIN 10 0.0005
899 VISUAL ACUITY REDUCED 17 0.0005
900 SKIN FISSURES 10 0.0005
901 EYE SWELLING 19 0.0005
902 HOSPITALISATION 78 0.0005
903 ANAPHYLACTIC REACTION 28 0.0005
904 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
905 TOXICITY TO VARIOUS AGENTS 85 0.0005
906 PRODUCT PHYSICAL ISSUE 10 0.0005
907 SNEEZING 11 0.0005
908 RASH MACULAR 17 0.0005
909 DRUG DOSE OMISSION 79 0.0005
910 ASTHMA 54 0.0005
911 MENTAL STATUS CHANGES 13 0.0005
912 HYPOACUSIS 20 0.0005
913 PARAESTHESIA 73 0.0005
914 PRODUCT PRESCRIBING ISSUE 10 0.0005
915 DIABETIC KETOACIDOSIS 11 0.0005
916 ANHEDONIA 12 0.0005
917 EYE DISORDER 15 0.0005
918 DRUG ADMINISTRATION ERROR 14 0.0005
919 NO ADVERSE EVENT 81 0.0004
920 DRY MOUTH 36 0.0004
921 EYE PAIN 25 0.0004
922 HYPERHIDROSIS 57 0.0004
923 LABORATORY TEST ABNORMAL 13 0.0004
924 MENTAL DISORDER 19 0.0004
925 OSTEONECROSIS 14 0.0004
926 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
927 ANXIETY 120 0.0004
928 OCULAR HYPERAEMIA 20 0.0004
929 DRY SKIN 56 0.0004
930 OSTEOPOROSIS 17 0.0004
931 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 83 0.0004
932 COGNITIVE DISORDER 19 0.0004
933 MEMORY IMPAIRMENT 55 0.0004
934 ILLNESS 41 0.0004
935 PROCEDURAL PAIN 11 0.0004
936 DISCOMFORT 24 0.0004
937 BURNING SENSATION 27 0.0004
938 INTENTIONAL PRODUCT MISUSE 33 0.0004
939 EAR INFECTION 10 0.0004
940 SURGERY 22 0.0004
941 PSORIASIS 49 0.0004
942 FLUSHING 38 0.0004
943 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26 0.0004
944 SEIZURE 42 0.0004
945 DRUG EFFECT INCOMPLETE 13 0.0004
946 UNEVALUABLE EVENT 27 0.0004
947 GYNAECOMASTIA 11 0.0004
948 NERVOUS SYSTEM DISORDER 11 0.0004
949 DRUG RESISTANCE 9 0.0004
950 SKIN IRRITATION 16 0.0003
951 ILL-DEFINED DISORDER 21 0.0003
952 DYSKINESIA 14 0.0003
953 BLINDNESS 14 0.0003
954 SPEECH DISORDER 18 0.0003
955 PRODUCT DOSE OMISSION ISSUE 101 0.0003
956 COLITIS ULCERATIVE 15 0.0003
957 NEOPLASM MALIGNANT 22 0.0003
958 DEPRESSION 73 0.0003
959 DRY EYE 16 0.0003
960 BONE DENSITY DECREASED 10 0.0003
961 INJECTION SITE BRUISING 24 0.0003
962 ADVERSE DRUG REACTION 27 0.0003
963 PRODUCT SUBSTITUTION ISSUE 17 0.0003
964 INFLUENZA LIKE ILLNESS 24 0.0003
965 NERVOUSNESS 15 0.0003
966 INCORRECT DOSE ADMINISTERED 65 0.0003
967 PRODUCT ADHESION ISSUE 10 0.0003
968 PROSTATE CANCER 22 0.0003
969 RENAL CANCER 13 0.0003
970 INJECTION SITE PRURITUS 18 0.0003
971 THROAT IRRITATION 12 0.0003
972 DISTURBANCE IN ATTENTION 14 0.0003
973 DEVICE ISSUE 23 0.0003
974 ABNORMAL BEHAVIOUR 10 0.0003
975 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
976 DEPRESSED MOOD 12 0.0002
977 AGITATION 16 0.0002
978 DEVICE MALFUNCTION 15 0.0002
979 DEVICE DISLOCATION 9 0.0002
980 BLADDER CANCER 12 0.0002
981 INJECTION SITE REACTION 14 0.0002
982 INJURY 14 0.0002
983 MIGRAINE 19 0.0002
984 PRODUCT QUALITY ISSUE 27 0.0002
985 EYE IRRITATION 11 0.0002
986 DRUG EFFECT DECREASED 10 0.0002
987 AGGRESSION 9 0.0002
988 INJECTION SITE PAIN 55 0.0002
989 INJECTION SITE HAEMORRHAGE 14 0.0002
990 ACNE 13 0.0002
991 INJECTION SITE ERYTHEMA 21 0.0002
992 IRRITABILITY 10 0.0002
993 BREAST CANCER 15 0.0002
994 EMOTIONAL DISTRESS 19 0.0002
995 SUICIDAL IDEATION 13 0.0001